Published Online: Oct 09 2020
DOI: 10.1002/wnan.1676
The cover image is based on the Advanced Review Nanotechnology's application in Type 1 diabetes by Wen Pan et al., https://doi.org/10.1002/wnan.1645.
Abstract
Full article on Wiley Online Library:
HTML |
PDF
Haotian Sun, William Erdman, Yuan Yuan, Mohamed Alaa Mohamed, Ruosen Xie, Yuyuan Wang, Shaoqin Gong, Chong Cheng
Published Online: Jul 03 2020
DOI: 10.1002/wnan.1653
As a unique class of nanocarriers with inner cavities enclosed by network‐like polymer shells, crosslinked polymer nanocapsules have been broadly studied as the platforms for therapeutic delivery, bioimaging, and theranostic applications.
Abstract
Full article on Wiley Online Library:
HTML |
PDF
Jessica C. Hsu, Lenitza M. Nieves, Oshra Betzer, Tamar Sadan, Peter B. Noël, Rachela Popovtzer, David P. Cormode
Published Online: May 22 2020
DOI: 10.1002/wnan.1642
Schematic illustration of the development of nanoparticles as contrast agents for newly emerged multi‐energy X‐ray imaging modalities. These nanoparticle X‐ray agents are developed to be renally clearable, long circulating, theranostic, targeted, or for cell tracking, and are used in conjunction with novel X‐ray imaging technologies.
Abstract
Full article on Wiley Online Library:
HTML |
PDF
Wen Pan, Xueying Zheng, Guiyuan Chen, Lanhong Su, Sihui Luo, Wei Wang, Shandong Ye, Jianping Weng, Yuanzeng Min
Published Online: May 22 2020
DOI: 10.1002/wnan.1645
The application of nanotechnology combing with immunology in the diagnosis, treatment, and islet cells translation of T1D.
Abstract
Full article on Wiley Online Library:
HTML |
PDF
Manman Xie, Yaolin Xu, Jing Huang, Yuancheng Li, Liya Wang, Lily Yang, Hui Mao
Published Online: May 20 2020
DOI: 10.1002/wnan.1644
Advantages of sub‐5 nm nanoparticles.
Abstract
Full article on Wiley Online Library:
HTML |
PDF
Fengrong Zhang, Qingyuan Wu, Huiyu Liu
Published Online: May 11 2020
DOI: 10.1002/wnan.1643
NIR light‐triggered nanomaterials‐based prodrugs have received widespread attention in cancer therapy. Here, we will discuss the diversified activation strategies and focus on the bioapplications of nanomaterials‐based prodrugs.
Abstract
Full article on Wiley Online Library:
HTML |
PDF
Pascal Bouvain, Sebastian Temme, Ulrich Flögel
Published Online: May 07 2020
DOI: 10.1002/wnan.1639
Labelling approaches for 19F MRI
Abstract
Full article on Wiley Online Library:
HTML |
PDF
Timothy Cuneo, Haifeng Gao
Published Online: May 04 2020
DOI: 10.1002/wnan.1640
Hyperbranched polymers that have tunable compositions, molecular weights and multiple peripheral chain‐end groups have received more and more attentions to be used as biomaterials for tissue scaffolds, delivery carriers to encapsulate various therapeutic and diagnostic probes.
Abstract
Full article on Wiley Online Library:
HTML |
PDF
Sydney D. Menikheim, Erin B. Lavik
Published Online: May 02 2020
DOI: 10.1002/wnan.1641
Self‐healing biomaterials have the potential to be used clinically in a wide variety of medical applications; however, issues with toxicity, robustness, and reproducibility of these materials in the complex environments of the body must first be addressed.
Abstract
Full article on Wiley Online Library:
HTML |
PDF
Keman Cheng, Qinglin Kang, Xiao Zhao
Published Online: May 28 2020
DOI: 10.1002/wnan.1646
Biogenic nanoparticles can not only effectively deliver immunotherapeutic drugs to tissues and cells, but also deliver antigens and adjuvants to secondary lymphoid organ. More importantly, Biogenic nanoparticles are allowed to carry or express multivalent antigens to realize multi‐antigens specific adaptive immunity. Compared with traditional formulations, nanotechnology may significantly improve the therapeutic effect and change the pattern of cancer immunotherapy.
Abstract
Full article on Wiley Online Library:
HTML |
PDF
